KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ginkgo Bioworks Holdings (DNA) Operating Margin (2020 - 2025)

Ginkgo Bioworks Holdings (DNA) has disclosed Operating Margin for 4 consecutive years, with 516.68% as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Operating Margin rose 46422.0% year-over-year to 516.68%, compared with a TTM value of 398.9% through Dec 2023, up 6351.0%, and an annual FY2024 reading of 595486.17%, down 33398265.0% over the prior year.
  • Operating Margin was 516.68% for Q3 2023 at Ginkgo Bioworks Holdings, down from 228.57% in the prior quarter.
  • Across five years, Operating Margin topped out at 9472.54% in Q4 2020 and bottomed at 1171.34% in Q4 2021.
  • Average Operating Margin over 4 years is 368.11%, with a median of 258.71% recorded in 2020.
  • The sharpest move saw Operating Margin crashed -1064388bps in 2021, then soared 93274bps in 2022.
  • Year by year, Operating Margin stood at 9472.54% in 2020, then plummeted by -112bps to 1171.34% in 2021, then surged by 80bps to 238.6% in 2022, then crashed by -117bps to 516.68% in 2023.
  • Business Quant data shows Operating Margin for DNA at 516.68% in Q3 2023, 228.57% in Q2 2023, and 267.34% in Q1 2023.